Hosted on MSN
What To Know About Graft vs. Host Disease (GVHD)
Graft vs. host disease (GVHD) can occur after a stem cell transplant from a donor. Transplants replace unhealthy cells with healthy blood-forming cells, which can treat some cancers. GVHD happens when ...
FAYETTEVILLE – Arkansas may be the fifth seed at this week’s SEC Softball Tournament, but will also open action at the event on Wednesday as the No. 1 team in college softball for the first time in ...
The European Medicines Agency (EMA) has recommended the refusal of marketing authorization for Rezurock (belumosudil) for treating patients 12 years or older with chronic graft-vs-host disease (cGvHD) ...
Graft-versus-host disease (GVHD) following liver transplantation remains a rare but devastating complication, characterised by donor immunocompetent cells initiating an immune attack against host ...
Fred Hutch bone marrow transplant and GVHD expert Dr. Geoffrey Hill explains how a new approach has changed the BMT landscape, where research is headed next Now, more than 1.5 million transplants have ...
Hematopoietic stem cell transplantation (HSCT) remains a vital treatment for a variety of haematologic malignancies and non‐malignant disorders. The procedure, involving the transfer of multipotent ...
MiNK Therapeutics receives an NIAID grant to develop iNKT cell therapies for preventing graft-versus-host disease in stem cell transplants. MiNK Therapeutics, Inc., a biopharmaceutical company ...
Impact of radiation dose in multi-isocentric volumetric arc-based total body irradiation on oncological outcomes in allogenic stem cell transplantation. Chi-square analysis showing predictors of ...
Paris, October 17, 2025. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a negative opinion on the marketing authorisation application for Rezurock ...
Certain foods can be unsafe or cause GI pain when you’re managing graft-versus-host disease (GVHD). To prevent uncomfortable symptoms or healing issues, dietitians recommend avoiding these foods.
The MarketWatch News Department was not involved in the creation of this content. Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results